TrialCPT: pharmacometrics & systems pharmacology2023

Population pharmacokinetics of molnupiravir in adults with COVID-19: Lack of clinically important exposure variation across individuals.

Sébastien Bihorel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.